-
公开(公告)号:EP0486022A3
公开(公告)日:1993-01-13
申请号:EP91119451.2
申请日:1991-11-14
申请人: Eisai Co., Ltd.
发明人: Yoshimura, Hiroyuki , Abe, Shinya , Kawahara, Tetsuya , Shimomura, Naoyuki , Okano, Kazuo , Clark, Richard Steven John , Mori, Takashi , Miyazawa, Shuhei , Hashida, Ryoichi , Muramoto, Kenzo , Harada, Koukichi , Inoue, Takashi , Shirota, Hiroshi , Chiba, Kenichi , Kusube, Kenichi , Horie, Toru , Suzuki, Takeshi , Yamatsu, Isao
CPC分类号: C07C255/41 , C07C39/40 , C07C43/202 , C07C43/23 , C07C43/253 , C07C45/00 , C07C47/575 , C07C59/52 , C07C59/64 , C07C59/72 , C07C59/90 , C07C69/734 , C07C69/738 , C07C251/48 , C07C2601/08
摘要: The present invention concerns naphthalene derivatives of the formula:
with specific meanings for the substituents R 1 to R 4 and Y and Z. The above compounds are useful as medicaments for the treating of diseases resulting in an increased production of prostaglandin or leukotrines, for treating an inflammatory disease and for treating a disease selected from chronic rheumatoid arthritis, osteoarthritis, shoulder periarthritis, cervicobrachial syndrome and lumbago.摘要翻译: 本发明涉及下式的萘衍生物:具有对取代基R 1至R 4以及Y和Z具有特定含义的下式:上述化合物可用作治疗导致产生增加的疾病的药物 的前列腺素或白细胞介素,用于治疗炎性疾病和治疗选自慢性类风湿性关节炎,骨关节炎,肩关节周围炎,子宫颈综合征和腰痛的疾病。
-
公开(公告)号:EP0486022A2
公开(公告)日:1992-05-20
申请号:EP91119451.2
申请日:1991-11-14
申请人: Eisai Co., Ltd.
发明人: Yoshimura, Hiroyuki , Abe, Shinya , Kawahara, Tetsuya , Shimomura, Naoyuki , Okano, Kazuo , Clark, Richard Steven John , Mori, Takashi , Miyazawa, Shuhei , Hashida, Ryoichi , Muramoto, Kenzo , Harada, Koukichi , Inoue, Takashi , Shirota, Hiroshi , Chiba, Kenichi , Kusube, Kenichi , Horie, Toru , Suzuki, Takeshi , Yamatsu, Isao
CPC分类号: C07C255/41 , C07C39/40 , C07C43/202 , C07C43/23 , C07C43/253 , C07C45/00 , C07C47/575 , C07C59/52 , C07C59/64 , C07C59/72 , C07C59/90 , C07C69/734 , C07C69/738 , C07C251/48 , C07C2601/08
摘要: The present invention concerns naphthalene derivatives of the formula:
with specific meanings for the substituents R 1 to R 4 and Y and Z. The above compounds are useful as medicaments for the treating of diseases resulting in an increased production of prostaglandin or leukotrines, for treating an inflammatory disease and for treating a disease selected from chronic rheumatoid arthritis, osteoarthritis, shoulder periarthritis, cervicobrachial syndrome and lumbago.摘要翻译: 本发明涉及下式的萘衍生物:具有对取代基R 1至R 4以及Y和Z具有特定含义的下式:上述化合物可用作治疗导致产生增加的疾病的药物 的前列腺素或白细胞介素,用于治疗炎性疾病和治疗选自慢性类风湿性关节炎,骨关节炎,肩关节周围炎,子宫颈综合征和腰痛的疾病。
-
公开(公告)号:EP0486022B1
公开(公告)日:1996-02-07
申请号:EP91119451.2
申请日:1991-11-14
申请人: Eisai Co., Ltd.
发明人: Yoshimura, Hiroyuki , Abe, Shinya , Kawahara, Tetsuya , Shimomura, Naoyuki , Okano, Kazuo , Clark, Richard Steven John , Mori, Takashi , Miyazawa, Shuhei , Hashida, Ryoichi , Muramoto, Kenzo , Harada, Koukichi , Inoue, Takashi , Shirota, Hiroshi , Chiba, Kenichi , Kusube, Kenichi , Horie, Toru , Suzuki, Takeshi , Yamatsu, Isao
CPC分类号: C07C255/41 , C07C39/40 , C07C43/202 , C07C43/23 , C07C43/253 , C07C45/00 , C07C47/575 , C07C59/52 , C07C59/64 , C07C59/72 , C07C59/90 , C07C69/734 , C07C69/738 , C07C251/48 , C07C2601/08
-
-